sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Position on Mural Oncology plc
The Vanguard Group, Inc. has disclosed its current interests in the securities of Mural Oncology plc under Rule 8.3 of the Irish Takeover Panel Act, 1997. As of July 10th, 2025, Vanguard holds 772,675 ordinary shares, amounting to a 4.47% stake in Mural Oncology. This marks their current significant shareholding in Mural Oncology, represented by $0.01 ordinary shares.
No dealings were disclosed apart from the sale of 64 such shares at a price of $2.48 USD each. Furthermore, the document clarifies that there are no cash-settled or stock-settled derivatives or additional purchase agreements pertaining to these securities. Vanguard also confirms the absence of any indemnity or other dealing arrangements, as well as agreements concerning options or derivatives related to voting rights or security acquisition or disposal.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.